GCG Deal Announcement | CREA Inversión advised Mimo Biosciences
CREA Inversión advised Mimo Biosciences in the capital increase of Sanitas, Gutinver and private investor.
Mimo Bioscience is a spin-off of the Cima University of Navarra that specialises in preclinical research services in the field of onco-hematology.
Sanitas is a leading health insurance provider in Spain, offering a wide range of services to ensure comprehensive healthcare coverage.
The transaction was led by Ignacio Olábarri, Managing Partner. Read more at this link.
/https://storage.googleapis.com/ggi-backend-prod/public/media/5051/LOGO-SQUARE-Website-CREA-Inversion.png){kind=logo}
/https://storage.googleapis.com/ggi-backend-prod/public/media/3865/Ignacio-Olabarri-Santos_CREA-Inversion_b&w-NEW.png)
/https://storage.googleapis.com/ggi-backend-prod/public/media/3777/CREA-Inversion_Logo.png){kind=logo}
/https://storage.googleapis.com/ggi-backend-prod/public/media/5023/GCG-Capital-Logo.jpg){kind=logo}
/https://storage.googleapis.com/ggi-backend-prod/public/media/5051/LOGO-SQUARE-Website-CREA-Inversion.png){kind=logo}
/https://storage.googleapis.com/ggi-backend-prod/public/media/5213/LOGO-SQUARE-Website-XLCS.png){kind=logo}
/https://storage.googleapis.com/ggi-backend-prod/public/media/5148/LOGO-SQUARE-Website-Weibull-M&A.png){kind=logo}
/https://storage.googleapis.com/ggi-backend-prod/public/media/5777/Delphi-Advisors_Logo_sq.png){kind=logo}